Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Appointed director
Quarterly results
Consulting agrmnt
Employment agrmnt
Asset disposition
|
|
REPROS THERAPEUTICS INC. (RPRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2019 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 0% stake in Repros Therapeutics Inc. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/02/2018 |
SC 13G/A
| Rosalind Advisors, Inc. reports a 8.4% stake in Repros Therapeutics Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/12/2013 |
SC 13G/A
| BAKER BROS ADVISORS LLC reports a 12.4% stake in Repros Therapeutics Inc. |
| 03/21/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 12/27/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 05/23/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 03/12/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 04/26/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/09/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/05/2010 |
SC 13G/A
| REPROS THERAPEUTICS INC. has filed a Schedule 13D for Repros Therapeutics Inc. |
| 01/05/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 05/04/2009 |
SC 13G/A
| Vermillion Asset Management LLC reports a 2.4% stake in Repros Therapeutics Inc. |
| 02/17/2009 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in REPROS THERAPEUTICS INC. |
| 02/17/2009 |
SC 13G/A
| Vermillion Asset Management LLC reports a 12.3% stake in Repros Therapeutics Inc. |
| 02/13/2009 |
SC 13G/A
| Visium Asset Management, LP reports a 4.6% stake in Repros Therapeutics Inc. |
| 02/09/2009 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 0% stake in REPROS THERAPEUTICS INC. |
| 10/09/2008 |
SC 13G/A
| Vermillion Asset Management LLC reports a 12.6% stake in Repros Therapeutics Inc. |
| 03/12/2008 |
SC 13G/A
| Efficacy Capital, Ltd. reports a 19.8% stake in REPROS THERAPEUTICS, INC. |
| 03/04/2008 |
SC 13G/A
| Efficacy Biotech Fund L.P. reports a 19.2% stake in REPROS THERAPEUTICS, INC. |
| 02/14/2008 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 6.6% stake in REPROS THERAPEUTICS INC. |
| 02/14/2008 |
SC 13G/A
| Visium Asset Management, LP reports a 9.2% stake in Repros Therapeutics, Inc |
| 02/14/2008 |
SC 13G/A
| ORBIMED ADVISORS LLC reports a 2.6% stake in Repros Therapeutics Inc. |
| 01/08/2008 |
SC 13G/A
| Efficacy Biotech Fund L.P. reports a 18.8% stake in REPROS THERAPEUTICS, INC. |
| 01/03/2008 |
SC 13G/A
| Efficacy Biotech Fund L.P. reports a 18.5% stake in REPROS THERAPEUTICS, INC. |
| 12/24/2007 |
SC 13G/A
| Efficacy Biotech Fund L.P. reports a 17.6% stake in REPROS THERAPEUTICS, INC. |
| 12/20/2007 |
SC 13G/A
| Efficacy Biotech Fund L.P. reports a 16.8% stake in REPROS THERAPEUTICS, INC. |
| 12/18/2007 |
SC 13G/A
| Efficacy Biotech Fund L.P. reports a 16.1% stake in REPROS THERAPEUTICS, INC. |
| 12/10/2007 |
SC 13G/A
| Efficacy Biotech Fund L.P. reports a 14.9% stake in REPROS THERAPEUTICS, INC. |
| 12/05/2007 |
SC 13G/A
| Efficacy Biotech Fund L.P. reports a 14.1% stake in REPROS THERAPEUTICS, INC. |
| 10/31/2007 |
SC 13G/A
| Efficacy Capital, Ltd. reports a 13.2% stake in REPROS THERAPEUTICS, INC. |
| 05/10/2007 |
SC 13G/A
| MORGAN STANLEY reports a 0% stake in REPROS THERAPEUTICS INC |
|
|
|